Rare diseases
541 results
1 - 100
Interventions for the treatment of Paget's disease of the vulva: Cochrane systematic review- Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita
- Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
- Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
- Vaccines for preventing plague: Cochrane systematic review
- Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B
- Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules
- Medical treatment for botulism: Cochrane systematic review
- Natalizumab for induction of remission in Crohn's disease
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Cemented, cementless or hybrid fixation options in total knee arthroplasty for osteoarthritis and other non-traumatic diseases: Cochrane systematic review
- Drug treatment for myotonia
- Sulfasalazine for ankylosing spondylitis
- Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
- Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review
- Notification and support for people exposed to the risk of Creutzfeldt‐Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)
- Enzyme replacement and substrate reduction therapy for Gaucher disease
- Physical training for McArdle disease: Cochrane systematic review
- Metformin for preventing the progression of chronic kidney disease
- Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
- Topical tacrolimus for atopic dermatitis
- Antiviral agents for treatment of herpes simplex virus infection in neonates: Cochrane systematic review
- Antibiotics for syphilis diagnosed during pregnancy
- Methotrexate for ankylosing spondylitis
- Pharmacological treatments for Friedreich ataxia
- Surgery for Dupuytren's contracture of the fingers
- Enzyme replacement therapy for late‐onset Pompe disease
- Pentoxifylline for alcoholic hepatitis
- Enzyme replacement therapy for Anderson‐Fabry disease
- Abatacept for rheumatoid arthritis
- Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity
- Treadmill training for patients with Parkinson's disease
- Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
- The impact of surgical therapies for inflammatory bowel disease on female fertility
- Colchicine for primary biliary cirrhosis
- Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
- Interventions for atypical haemolytic uraemic syndrome
- Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Oral adsorbents for preventing or delaying the progression of chronic kidney disease
- Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review
- Interventions for hyperthyroidism pre-pregnancy and during pregnancy: Cochrane systematic review
- Vaccines for preventing pneumococcal infection in adults
- Bisphosphonates for Paget's disease of bone in adults
- Immunosuppressive treatment for non‐systemic vasculitic neuropathy
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Surgical interventions for early squamous cell carcinoma of the vulva: Cochrane systematic review
- Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children
- Cromolyn sodium for the prevention of chronic lung disease in preterm infants
- Glucocorticosteroids for primary sclerosing cholangitis: Cochrane systematic review
- Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
- Treatment for familial amyotrophic lateral sclerosis/motor neuron disease
- Interventions for managing oral ulcers in Behçet's disease
- Colony‐stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia
- Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection: Cochrane systematic review
- Calcium channel blockers for people with chronic kidney disease requiring dialysis
- Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease
- Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
- Interventions for toxic epidermal necrolysis
- Fludrocortisone for orthostatic hypotension
- Febuxostat for treating chronic gout
- Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy: Cochrane systematic review
- Interferon for acute hepatitis C: Cochrane systematic review
- Interventions for treating intrahepatic cholestasis in people with sickle cell disease
- Surgery for chronic arthropathy in people with haemophilia
- Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non‐radiographic axial spondyloarthritis)
- Surgical removal versus retention for the management of asymptomatic disease‐free impacted wisdom teeth
- Statins for acute coronary syndrome
- Shouldice technique versus other open techniques for inguinal hernia repair: Cochrane systematic review
- Treatment of infantile spasms
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Interventions for cutaneous Bowen's disease
- Conjugate Haemophilus influenzae type b vaccines for sickle cell disease
- Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation: Cochrane systematic review
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Lipid‐lowering agents for nephrotic syndrome
- Effectiveness of different treatment modalities for the management of adult‐onset granulosa cell tumours of the ovary (primary and recurrent)
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Anti‐vascular endothelial growth factor biosimilars for neovascular age‐related macular degeneration
- Bezafibrate for primary biliary cirrhosis: Cochrane systematic review
- Singing for children and adults with bronchiectasis: Cochrane systematic review
- Topical and oral steroids for otitis media with effusion (OME) in children
- Pharmacological interventions for painful sickle cell vaso‐occlusive crises in adults
- Immunosuppressive agents for treating IgA nephropathy
- Exercise programmes for ankylosing spondylitis
- Information provision for people with multiple sclerosis
- Interferon after surgery for women with advanced (Stage II‐IV) epithelial ovarian cancer
- Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newborn infants
- Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome